Over 200 number of people participated in this year’s Hackathon
Winners selected from ‘professional hackers’ and ‘students’ categories: first prize of INR 100,000 and runner up prize of INR 50,000
BENGALURU- October 16, 2018 – Mylan Pharmaceuticals Private Limited announced the winners of its second edition of the Mylan Hackathon held in Bengaluru. The two-day event took place on October 13 and 14, at Mylan’s Global Centre in the city, where students and professionals connected and collaborated with people at Mylan to innovate solutions that address real-world health challenges.
Commenting on the initiative, Mylan spokesperson Mr. Rakesh Bamzai, President – India and Emerging Markets said, “We are proud to be one of the few pharmaceutical companies in the world to host a hackathon for digital innovation. Initiatives such as these foster engagement and collaboration between students, professionals and institutions, to develop innovative and cost-effective solutions for real-world health problems and enhance access to affordable medicines. At Mylan, the Hackathon initiative focuses not only on the current challenges in Healthcare, but also on developing solutions for the future.”
Winners - Professional Hackers Category
- Team Smart from Atos wins for their novel solution to adherence of treatment of TB patients
Winners – Students Category
- Team from Sri Sairam Institute of Technology wins for its solution for tracking ARV medicines till it reaches the consumer
This year, the Hackathon teams were asked to ‘Hack for a Cause’ to find solutions to leading healthcare challenges such as adverse event / side effect reporting of pharmaceutical products; detection of early signs and symptoms of cancer and addressing the resource scarcity problem by automating preliminary analysis of reports; a patient’s real-world outcome tracking through technology/AI; patient’s adherence to TB treatment and traceability of Mylan’s ARV drugs to the end consumer.
The 2018 event attracted more than 200 participants from 44 cities across India who were joined by Mylan employees and Mylan coaches. The two-day event included top notch giveaways, spot quizzes and a session with Shakthi Vadakkepat, founder of The Quill, who spoke to the participants about innovation driven solutions to today's medical problems.
One of the members of the winning team Mr. Ganesh Mahadevan said, “This event was an exceptional learning platform for me. It allowed me to interact and collaborate with brilliant like-minded innovators to develop solutions that could have a positive impact on patients and the industry. I believe that anyone who wants to find viable solutions for health problems should participate in the Mylan Hackathon.”
Mylan held its first hackathon in India in 2016 and has since been fueling the push for new creative and innovative solutions in the healthcare segment for patients, payers, providers and other healthcare professionals. Mylan Pharmaceuticals, a global pharmaceutical company has an ambitious mission of providing the world’s 7 billion people access to high quality medicine. The Hackathon is conducted by Mylan in India and globally.
About Mylan
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 7,500 marketed products around the world, including antiretroviral therapies on which more than 40% of people being treated for HIV/AIDS globally depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at Mylan.com. We routinely post information that may be important to investors on our website at investor.mylan.com.
